Key facts
- UpHill’s last known valuation is $23.6M (Mar 2024).
- It has raised $12.5M; the latest was PE Growth/Expansion in Dec 2025.
- Notable investors include Redstone VC, Explorer Investments, Oxy Capital, Caixa Capital, Brighteye Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for UpHill
- ·The full record, as it builds
Funding rounds
No funding rounds for UpHill are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UpHill
Developer of a clinical pathway software designed to integrate with existing hospital information systems to automate tasks and bridge gaps in care. The company offers software orchestrating care where hospitals have a comprehensive view of their patient's status throughout their journeys as individuals and as a population, including history and expected next steps, enabling the healthcare industry to automate medical tests and appointments, monitor patients after discharge, intelligently interpret patients' answers, present the next best actions to be done, and get records proposed to the electronic health records system.
- Sector
- Healthcare
- HQ
- Covilha, Portugal
- Founded
- 2015
- Employees
- 46
- Website
- uphillhealth.com/
- Ownership
- Privately Held (backing)
UpHill doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UpHill shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UpHill in its N-PORT filings yet. We sweep new filings monthly.